SEC Form 4 · accession 0001477932-17-000030
PREMIER BIOMEDICAL INC · BIEI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William A. Hartman
Officer — CEO and President · Director · 10% Owner
Period of report
Aug 19, 2016
Accepted (ET)
Jan 4, 2017 · 6:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515740
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2016 | M | 4,000,000 | $0.00 | A | 7,000,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1 | $0.00 | Aug 19, 2016 | M | 4,000,000 | D | Jun 21, 2010 | Jun 21, 2020 | Common Stock | 4,000,000 | 13,000,000 | D |
Explanation of responses
- F1Price is $0.00001.